Critical Illness Insurance Market is Sustained to Record a Perfect CAGR of 15.35% During Forecast 2019-2025


Market Highlights:
Critical illness insurance is a type of insurance, where the insurer comes in a contract to make a lump sum cash payment if the policyholder is diagnosed with some specific critical disease as a part of the insurance policy. Critical illness insurance is also known as critical insurance cover or dread disease policy.
The global Critical Illness Insurance Market is expected to register a CAGR of 15.35% during the forecast period, with a market value of USD 67,960.81 million by 2025.
The increasing cases of critical illness and increasing out of pocket expenditure for the insured and uninsured population are expected to drive the growth of the critical illness insurance market. However, lack of awareness about critical illness insurance is expected to hamper the market growth during the forecast period.
Competitive Landscape:
·         China Life Insurance Company
·         Allianz
·         Ping An Insurance
·         Aviva
·         Prudential
·         Aegon
·         AXA
·         Sun Life Financial
·         Aflac Incorporated
·         Huaxia Life Insurance Co
·         AIG
·         MetLife Services and Solutions
·         Zurich
Segment Analysis:
·         The global critical illness insurance market has been divided based on application and region.
·         The market, based on application, has been bifurcated into cancer, heart attack, stroke, and others. In 2018, the cancer segment held the largest market share owing to the rise in the number of cancer cases. For instance, an estimated 1,735,350 new cases of cancer were diagnosed in the US and 609,640 people died from the disease in 2018.
Regional Analysis:
The global critical illness insurance market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is likely to hold the largest share of the global critical illness insurance market during the assessment period. The rising prevalence of chronic diseases, including cancer and rising medical expenses, are expected to support the dominance of the Americas during the forecast period. Moreover, in the US, there has been a significant rise in the number of insured populations in the past few years. For instance, the percentage of the uninsured population in the US was about 14% in 2008, and this came down to nearly 8.5% in 2018.
Furthermore, about 99.1% of the population aged 65 and above were insured in 2018 in the US. The Europe market established substantial growth in the market due to the high prevalence of critical illnesses such as cancer, heart attack, and stroke, among others in this region. Asia-Pacific is estimated to be the fastest-growing region in the global market due to the increasing geriatric population, presence of expensive health facilities and an increase in the demand for health insurance policies in high populous countries such as India and China. The critical illness insurance market in the Middle East & Africa is expected to witness gradual growth due to the increasing life expectancy, enlarging middle class, and population growth. Moreover, the launch of the life insurance reform project in 2016 in the United Arab Emirates would support the market growth in this region.
Related Reports:
https://www.marketresearchfuture.com/reports/health-insurance-market-8227


Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote...
Read more

Pancreatic Cancer Market: America to Command the Largest Share

Market Overview: Pancreatic cancer can be defined as an enlarged tumor, which is generally caused by malignant cells present in the tissues of the pancreas. This type of cancer is generally caused due to drinking alcohol, smoking, genetic factors, radiotherapy in the past, obesity, inflammation of the pancreas, and diabetes mellitus. It is a type of cancer that starts in the pancreas and is a highly lethal disease. The global Pancreatic Cancer Market , as per a report by Market Research Future (MRFR) is touted to register 8.1% CAGR during the forecast period ( 2017-2023 ). The dearth of therapeutic approaches for early-stage detection has resulted in increased incidences of pancreatic cancer. Soaring prevalence of pancreatic cancer has resulted in germline mutations, thereby causing the defective genes to pass down to the children from their parents, thus making early detection of pancreatic cancer important. This has led to the growth of the market across the globe. Surging dem...
Read more

Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights: As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers. ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ...
Read more